{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:07:00Z","timestamp":1765609620945},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11739-014-1144-x","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T15:07:23Z","timestamp":1415027243000},"page":"321-328","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Tarang","family":"Taghvaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iradj","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Nagshvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafez","family":"Fakheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Neishaboori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"issue":"12","key":"1144_CR1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.MIB.0000187980.08686.18","volume":"11","author":"J Langhorst","year":"2005","unstructured":"Langhorst J, Elsenbruch S, Mueller T et al (2005) Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 11(12):1085\u20131091","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1144_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-3565(04)00441-0","volume":"3","author":"DS Fefferman","year":"2005","unstructured":"Fefferman DS, Farrell RJ (2005) Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol: the official clinical practice journal of the American Gastroenterological Association. 3(1):11\u201324","journal-title":"Clin Gastroenterol Hepatol: the official clinical practice journal of the American Gastroenterological Association."},{"issue":"12","key":"1144_CR3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ibd.20986","volume":"15","author":"AM Schoepfer","year":"2009","unstructured":"Schoepfer AM, Beglinger C, Straumann A et al (2009) Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 15(12):1851\u20131858","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1144_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2007.02.025","volume":"381","author":"I Angriman","year":"2007","unstructured":"Angriman I, Scarpa M, D\u2019Inca R et al (2007) Enzymes in feces: useful markers of chronic inflammatory bowel disease. Clin Chim Acta; International Journal Of Clinical Chemistry. 381(1):63\u201368","journal-title":"Clin Chim Acta; International Journal Of Clinical Chemistry."},{"issue":"5","key":"1144_CR5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","volume":"145","author":"SP Travis","year":"2013","unstructured":"Travis SP, Schnell D, Krzeski P et al (2013) Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 145(5):987\u2013995","journal-title":"Gastroenterology"},{"key":"1144_CR6","doi-asserted-by":"crossref","unstructured":"Walsh AJ, Ghosh A, Brain AO et al (2014) Comparing disease activity indices in ulcerative colitis. J Crohns Colitis 8(4):318\u2013325","DOI":"10.1016\/j.crohns.2013.09.010"},{"issue":"4","key":"1144_CR7","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2000.01924.x","volume":"95","author":"HA Carpenter","year":"2000","unstructured":"Carpenter HA, Talley NJ (2000) The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol 95(4):878\u2013896","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1144_CR8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2007.09.001","volume":"133","author":"S Nikolaus","year":"2007","unstructured":"Nikolaus S, Schreiber S (2007) Diagnostics of inflammatory bowel disease. Gastroenterology 133(5):1670\u20131689","journal-title":"Gastroenterology"},{"issue":"3","key":"1144_CR9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55(3):426\u2013431","journal-title":"Gut"},{"issue":"3","key":"1144_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2036.2006.03184.x","volume":"25","author":"D Desai","year":"2007","unstructured":"Desai D, Faubion WA, Sandborn WJ (2007) Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 25(3):247\u2013255","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1144_CR11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1157\/13100073","volume":"30","author":"JP Gisbert","year":"2007","unstructured":"Gisbert JP, Gonzalez-Lama Y, Mate J (2007) Role of biological markers in inflammatory bowel disease. Gastroenterol Hepatol 30(3):117\u2013129","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"1144_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger S et al (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119(1):15\u201322","journal-title":"Gastroenterology"},{"issue":"4","key":"1144_CR13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3748\/wjg.v7.i4.460","volume":"7","author":"JA Tibble","year":"2001","unstructured":"Tibble JA, Bjarnason I (2001) Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 7(4):460\u2013465","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1144_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","volume":"120","author":"A Bitton","year":"2001","unstructured":"Bitton A, Peppercorn MA, Antonioli DA et al (2001) Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120(1):13\u201320","journal-title":"Gastroenterology"},{"issue":"8","key":"1144_CR15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10350-008-9310-8","volume":"51","author":"AD Sutherland","year":"2008","unstructured":"Sutherland AD, Gearry RB, Frizelle FA (2008) Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum 51(8):1283\u20131291","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"1144_CR16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.47.3.404","volume":"47","author":"K Geboes","year":"2000","unstructured":"Geboes K, Riddell R, Ost A et al (2000) A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47(3):404\u2013409","journal-title":"Gut"},{"issue":"10","key":"1144_CR17","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/gut.34.10.1357","volume":"34","author":"K Bjerke","year":"1993","unstructured":"Bjerke K, Halstensen TS, Jahnsen F et al (1993) Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer\u2019s patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 34(10):1357\u20131363","journal-title":"Gut"},{"issue":"3","key":"1144_CR18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","volume":"54","author":"F Costa","year":"2005","unstructured":"Costa F, Mumolo MG, Ceccarelli L et al (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn\u2019s disease. Gut 54(3):364\u2013368","journal-title":"Gut"},{"issue":"3","key":"1144_CR19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/mp.50.3.113","volume":"50","author":"B Johne","year":"1997","unstructured":"Johne B, Fagerhol MK, Lyberg T et al (1997) Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 50(3):113\u2013123","journal-title":"Mol Pathol"},{"issue":"6","key":"1144_CR20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","volume":"12","author":"MR Konikoff","year":"2006","unstructured":"Konikoff MR, Denson LA (2006) Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12(6):524\u2013534","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1144_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3748\/wjg.14.53","volume":"14","author":"JY Xiang","year":"2008","unstructured":"Xiang JY, Ouyang Q, Li GD et al (2008) Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 14(1):53\u201357","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1144_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J Langhorst","year":"2008","unstructured":"Langhorst J, Elsenbruch S, Koelzer J et al (2008) Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 103(1):162\u2013169","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1144_CR23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.dld.2008.01.017","volume":"40","author":"RB Canani","year":"2008","unstructured":"Canani RB, Terrin G, Rapacciuolo L et al (2008) Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 40(7):547\u2013553","journal-title":"Dig Liver Dis : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver."},{"issue":"3\u20134","key":"1144_CR24","first-page":"117","volume":"51","author":"H Silberer","year":"2005","unstructured":"Silberer H, Kuppers B, Mickisch O et al (2005) Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 51(3\u20134):117\u2013126","journal-title":"Clin Lab"},{"issue":"1","key":"1144_CR25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2008.05.008","volume":"41","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, McNicholl AG (2009) Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 41(1):56\u201366","journal-title":"Dig Liver Dis: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver."},{"issue":"2","key":"1144_CR26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.crohns.2009.09.008","volume":"4","author":"V Garcia-Sanchez","year":"2010","unstructured":"Garcia-Sanchez V, Iglesias-Flores E, Gonzalez R et al (2010) Does fecal calprotectin predict relapse in patients with Crohn\u2019s disease and ulcerative colitis? J Crohns Colitis 4(2):144\u2013152","journal-title":"J Crohns Colitis"},{"issue":"2","key":"1144_CR27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","volume":"132","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens G, Sandborn WJ, Feagan BG et al (2007) A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132(2):763\u2013786","journal-title":"Gastroenterology"},{"issue":"9","key":"1144_CR28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00535-010-0244-2","volume":"45","author":"M Naganuma","year":"2010","unstructured":"Naganuma M, Ichikawa H, Inoue N et al (2010) Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients. J Gastroenterol 45(9):936\u2013943","journal-title":"J Gastroenterol"},{"issue":"4","key":"1144_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","volume":"61","author":"SP Travis","year":"2012","unstructured":"Travis SP, Schnell D, Krzeski P et al (2012) Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 61(4):535\u2013542","journal-title":"Gut"},{"issue":"6666","key":"1144_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298(6666):82\u201386","journal-title":"BMJ"},{"key":"1144_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1745-6215-8-17","volume":"8","author":"RM Cooney","year":"2007","unstructured":"Cooney RM, Warren BF, Altman DG et al (2007) Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials 8:17","journal-title":"Trials"},{"issue":"8","key":"1144_CR32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ibd.20933","volume":"15","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Bermejo F, Perez-Calle JL et al (2009) Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 15(8):1190\u20131198","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"1144_CR33","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/gut.2006.113431","volume":"56","author":"T Kaiser","year":"2007","unstructured":"Kaiser T, Langhorst J, Wittkowski H et al (2007) Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 56(12):1706\u20131713","journal-title":"Gut"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-014-1144-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1144-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:28:50Z","timestamp":1559424530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-014-1144-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s11739-014-1144-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}